Legumain and cathepsin-L expression in human unstable carotid plaque

被引:47
作者
Mattock, K. L.
Gough, P. J. [1 ]
Humphries, J.
Burnand, K.
Patel, L. [2 ]
Suckling, K. E. [2 ]
Cuello, F.
Watts, C. [3 ]
Gautel, M.
Avkiran, M.
Smith, A.
机构
[1] GSK Plc, King Of Prussia, PA 19406 USA
[2] GSK Plc, Stevenage, Herts, England
[3] Univ Dundee, Wellcome Trust Bioctr, Dundee, Scotland
关键词
Atherosclerosis; Carotid artery; Macrophages; Proteases; RGD; ASPARAGINYL ENDOPEPTIDASE; ATHEROSCLEROTIC PLAQUES; MAMMALIAN LEGUMAIN; MACROPHAGES; CELLS; MICE; ELECTROPHORESIS; PROTEINASES; DEGRADATION; ACTIVATION;
D O I
10.1016/j.atherosclerosis.2009.07.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The cysteine protease, legumain, is thought to have a role in the processing and activation of proteases such as cathepsin-L, which have been implicated in plaque rupture. This study aimed to determine: if legumain activity is up-regulated in unstable areas of plaque; the effect of legumain overexpression on the activity of cathepsin-L and the effect of mutation of the legumain RGD sequence on its cellular location. Methods and results: Legumain was measured in human carotid plaque extracts (n = 17) using a novel ELISA and modified activity assay. Unstable regions of plaque contained more than twice the amount of legumain protein (P < 0.001) and activity (P < 0.03) compared with stable regions of the same plaque. Overexpression of legumain in THP-1 macrophages using an adenoviral construct resulted in the processing of cathepsin-L from its 30 kDa to its 25 kDa form compared with controls. Conclusion: Unstable regions of plaque contain increased levels of active legumain. Over-expression of legumain in macrophages alters intracellular processing of cathepsin-L to its mature 25 kDa form. This may be a means by which legumain could contribute to plaque instability. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 89
页数:7
相关论文
共 34 条
[1]   Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase [J].
Chen, JM ;
Fortunato, M ;
Stevens, RAE ;
Barrett, AJ .
BIOLOGICAL CHEMISTRY, 2001, 382 (05) :777-783
[2]   Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase [J].
Chen, JM ;
Dando, PM ;
Rawlings, ND ;
Brown, MA ;
Young, NE ;
Stevens, RA ;
Hewitt, E ;
Watts, C ;
Barrett, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) :8090-8098
[3]   Cloning and expression of mouse legumain, a lysosomal endopeptidase [J].
Chen, JM ;
Dando, PM ;
Stevens, RAE ;
Fortunato, M ;
Barrett, AJ .
BIOCHEMICAL JOURNAL, 1998, 335 :111-117
[4]   Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment [J].
Choi, SJ ;
Kurihara, N ;
Oba, Y ;
Roodman, GD .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) :1804-1811
[5]   Cell death in the cardiovascular system [J].
Clarke, Murray ;
Bennett, Martin ;
Littlewood, Trevor .
HEART, 2007, 93 (06) :659-664
[6]   Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis [J].
Clerin, Valerie ;
Shih, Heather H. ;
Deng, Nanhua ;
Hebert, Gustave ;
Resmini, Christine ;
Shields, Kathleen M. ;
Feldman, Jeffrey L. ;
Winkler, Aaron ;
Albert, Leo ;
Maganti, Vasu ;
Wong, Anthony ;
Paulsen, Janet E. ;
Keith, James C., Jr. ;
Vlasuk, George P. ;
Pittman, Debra D. .
ATHEROSCLEROSIS, 2008, 201 (01) :53-66
[7]   Serial analysis of gene expression in human monocytes and macrophages [J].
Hashimoto, S ;
Suzuki, T ;
Dong, HY ;
Yamazaki, N ;
Matsushima, K .
BLOOD, 1999, 94 (03) :837-844
[8]   Multiple processing of procathepsin L to cathepsin L in vivo [J].
Ishidoh, K ;
Saido, TC ;
Kawashima, S ;
Hirose, M ;
Watanabe, S ;
Sato, N ;
Kominami, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 252 (01) :202-207
[9]   Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis [J].
Johansen, HT ;
Knight, CG ;
Barrett, AJ .
ANALYTICAL BIOCHEMISTRY, 1999, 273 (02) :278-283
[10]   Tissue pH determination for the detection of metabolically active, inflamed vulnerable plaques using near-infrared spectroscopy: An in-vitro feasibility study [J].
Khan, T ;
Soller, B ;
Naghavi, M ;
Casscells, W .
CARDIOLOGY, 2005, 103 (01) :10-16